To evaluate the diagnostic accuracy of T2 values in differentiating prostate cancer (PCa) from chronic prostatitis in a clinical cohort, with implications for improving patient management.
Key Findings:
T2 mapping provides quantitative T2 values that are independent of signal variations in standard imaging, enhancing diagnostic precision.
PCa was detected in 29 out of 55 patients, while chronic prostatitis was a common benign finding, highlighting the challenge in diagnosis.
T2 values may improve differentiation between PCa and chronic prostatitis compared to ADC values, suggesting a potential shift in diagnostic strategy.
Interpretation:
T2 mapping could enhance the diagnostic accuracy of mpMRI in distinguishing between malignant and benign prostate lesions, particularly in cases where chronic prostatitis mimics PCa, potentially leading to better patient outcomes.
Limitations:
Single-center study may limit generalizability.
Small sample size may affect statistical power.
Exclusion of patients with high PSA levels may bias results, potentially overlooking cases of aggressive PCa.
Conclusion:
T2 mapping shows promise as a quantitative tool for characterizing prostate lesions, potentially aiding in the differentiation of PCa from chronic prostatitis, which could significantly impact clinical decision-making.
by Tobias Hepp, Laura Kalmbach, Manuel Kolb, Petros Martirosian, Tom Hilbert, Wolfgang M. Thaiss, Mike Notohamiprodjo, Jens Bedke, Konstantin Nikolaou, Arnulf Stenzl, Stephan Kruck, Sascha Kaufmann
With its combination of UWF imaging, OCT integration, and intelligent review tools, the MonacoPro represents the next step in comprehensive retinal evaluation. By improving image quality, enhancing diagnostic confidence, and streamlining workflow, the system supports clinicians in delivering more efficient, informed, and patient-centered care.
